Positive Airway Pressure Devices Market To Reach $3.63 Billion By 2030

Positive Airway Pressure Devices Growth & Trends

The global positive airway pressure devices market size is estimated to reach USD 3.63 billion by 2030, registering a CAGR of 5.59% from 2025 to 2030, according to a new report by Grand View Research, Inc. The healthcare industry is facing challenges owing to the rapidly growing prevalence of obstructive sleep apnea and sleep apnea-associated chronic comorbidities. Obstructive sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. As per the global prevalence of obstructive sleep apnea estimates published in June 2022 by UpToDate, over 936 million individuals across the globe suffer from mild to severe sleep apnea.

Changing lifestyles owing to globalization and the adoption of unhealthy dietary habits are making individuals prone to obesity, Cardiovascular Diseases (CVDs), diabetes, and hypertension, which are forerunners of obstructive sleep apnea. As per the estimates published by the World Population Review, 36.2% of the U.S. population is diagnosed as obese. In addition, the rapidly increasing geriatric population coupled with increasing life expectancy is anticipated to contribute to the incidence rate of obstructive sleep apnea and directly drive the demand for positive airway pressure devices (PAP) devices. The COVID-19 pandemic restrained the growth of the market owing to multiple lockdowns and travel restrictions imposed by governments across the globe to curb the transmission rate.

In addition, the postponement of elective procedures and infrastructural changes in healthcare facilities to accommodate COVID-19 care facilities negatively impacted the procedural volume, which hindered market growth. Healthcare facilities and sleep centers recorded a declining trend in diagnostic and therapeutic procedural volume, restricting the growth of PAP devices. The American Academy of Sleep Medicine (AASM) introduced protocols to adopt virtual consultations to address the declining sleep studies volume. However, during the initial months of the pandemic, PAP machines were being used as the first line of treatment and as an alternative to ventilators in mechanical ventilation. Global government bodies are devising strategies to promote awareness levels among the population and promote the adoption of PAP machines. The availability of favorable reimbursement policies is further boosting product adoption.

 Request a free sample copy or view report summary: Positive Airway Pressure Devices Market Report

Positive Airway Pressure Devices Market Report Highlights

• The CPAP devices segment dominated the market in 2024, owing to the growing incidence of obstructive sleep apnea and CPAP is the first line of treatment as it is more economical than other PAP devices

• North America dominated the market in 2024, owing to the large patient pool, increasing disposable income levels, and presence of favorable insurance coverages

• The prevalence of obstructive sleep apnea in the male population of North America is recorded to be 15-30% and in females, it is 10-15%

• Key participants in the market are focusing on innovative product development strategies to expand their product portfolio and address the growing demand

• Some of the latest features being incorporated in PAP machines are noise reduction and softer material to enhance patient comfort and compliance.

Positive Airway Pressure Devices Market Segmentation

Grand View Research has segmented the global positive airway pressure devices market based on Product type, application, end user, region:

Positive Airway Pressure Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• CPAP

• APAP

• BiPAP

Positive Airway Pressure Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Obstructive Sleep Apnea

• Respiratory Failures

• COPD

Positive Airway Pressure Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Home Care Settings

• Hospitals & Clinics

• Others (Long-Term Care Facilities, etc.)

Positive Airway Pressure Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

List of Key Players in the Positive Airway Pressure Devices Market

• Koninklijke Philips N.V.

• Fisher & Paykel Healthcare Limited (

• Curative, Inc.

• ResMed

• Medtronic

• Servona GmbH

• Armstrong Medical Inc.

• Smiths Group plc

• Löwenstein Medical UK Ltd.